Sign in

CIK 0001649989

  • Non-accelerated filer
  • Smaller reporting company

Outlook Therapeutics, Inc.

Sign in to watch
Ticker
OTLK
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Sep 30
Incorporated
DE
Entity type
Operating
EIN
383982704
Phone
+1 609-619-3990
Business address
111 S. WOOD AVENUE, UNIT #100, ISELIN, NJ, 08830
Former names
Oncobiologics, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 71 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2021-02-03 Syntone Ventures LLC 10% owner Purchase +3,000,000 $1.00 $3.0M 19,823,045
2021-02-02 Sukhtian Ghiath M. Director Purchase +8,360,000 $1.00 $8.4M 10,820,630
2020-10-05 Haddadin Yezan Munther Director Grant or award · Stock Option (Right to Buy) +160,474 $0.51 $82K 160,474
2020-10-05 Sukhtian Faisal Ghiath Director Grant or award · Stock Option (Right to Buy) +151,721 $0.51 $78K 151,721
2020-10-05 Huang Andong Director Grant or award · Stock Option (Right to Buy) +77,805 $0.51 $40K 77,805
2020-10-05 THURMAN RANDY H Director Grant or award · Stock Option (Right to Buy) +396,809 $0.51 $204K 396,809
2020-10-05 Auffarth Gerd Director Grant or award · Stock Option (Right to Buy) +85,586 $0.51 $44K 85,586
2020-10-05 HILZINGER KURT J Director Grant or award · Stock Option (Right to Buy) +116,708 $0.51 $60K 116,708
2020-10-05 Gangolli Julian S Director Grant or award · Stock Option (Right to Buy) +150,748 $0.51 $77K 150,748
2020-10-01 KENYON LAWRENCE A CEO, Pres, CFO, Treas & Secy Grant or award · Stock Option (Right to Buy) +3,668,984 3,668,984
2020-10-01 Haddadin Yezan Munther Director Grant or award · Stock Option (Right to Buy) +290,372 290,372
2020-10-01 Sukhtian Faisal Ghiath Director Grant or award · Stock Option (Right to Buy) +296,352 296,352
2020-10-01 THURMAN RANDY H Director Grant or award · Stock Option (Right to Buy) +259,297 259,297
2020-10-01 HILZINGER KURT J Director Grant or award · Stock Option (Right to Buy) +217,602 217,602
2020-09-22 Haddadin Yezan Munther Director Purchase +10,000 $0.72 $7K 10,000
2020-09-17 Sukhtian Faisal Ghiath Director Purchase +10,000 $0.67 $7K 10,000
2020-09-14 THURMAN RANDY H Director Purchase +10,000 $0.62 $6K 11,875
2020-07-17 THURMAN RANDY H Director Grant or award · Stock Option (Right to Buy) +154,555 154,555
2020-07-17 THURMAN RANDY H Director Grant or award · Stock Option (Right to Buy) +210,000 210,000
2020-07-17 Sukhtian Faisal Ghiath Director Grant or award · Stock Option (Right to Buy) +135,000 135,000

Page 10 of 14 · 276 trades